Human complex I defects in neurodegenerative diseases (Q34747340)

4 August 2017

1 reference

title

Human complex I defects in neurodegenerative diseases (English)

1 reference

4 August 2017

1 reference

A H Schapira

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Biochimica et Biophysica Acta

4 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 August 2017

volume

1364

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

261-270

1 reference

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

DSP-4, a noradrenergic neurotoxin, produces more severe biochemical and functional deficits in aged than young rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Mitochondrial respiratory chain function in multiple system atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Mitochondrial defect in Huntington's disease caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Brain Cytochrome Oxidase in Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Platelets as a model for neurones?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Selective inhibition of complex I of the brain electron transport system by tetrahydroisoquinoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Maternal inheritance in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

A clinical and genetic study of familial Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Origin and functional consequences of the complex I defect in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Mitochondrial DNA analysis in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Oxidative stress in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Decreased ferritin levels in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Histochemical detection of apoptosis in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Mitochondrial control of nuclear apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

A genetic study of idiopathic torsion dystonia in the United Kingdom.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Dystonia as the major manifestation of Leigh's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Electron transfer complex I defect in idiopathic dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Respiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Complex I function in familial and sporadic dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Cerebellar ataxia in patients with Leber's hereditary optic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Leber's hereditary optic neuropathy. Clinical manifestations of the 15257 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Leber's hereditary optic neuropathy: no significant evidence for primary or secondary pathogenicity of the 15257 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

X-inactivation patterns in female Leber's hereditary optic neuropathy patients do not support a strong X-linked determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Platelet mitochondrial function in Leber's hereditary optic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

The mitochondrial DNA mutation ND6*14,484C associated with leber hereditary optic neuropathy, leads to deficiency of complex I of the respiratory chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Leber's hereditary optic neuropathy and complex I deficiency in muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2728%2898%2900032-2

10.1016/S0005-2728(98)00032-2

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference